Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07258173Phase 2Not Yet Recruiting

Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita

Role: collaborator

NCT05350462Unknown

Adoption of L-PZQ for Schistosomiasis by Endemic Counties - Social Science Research Study

Role: collaborator

NCT02105714Completed

Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders

Role: collaborator

All 3 trials loaded